262
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Two Constructed Antibody-Derived Delivery Vehicles for Targeting Oligodeoxynucleotides to Prostate Tumors Expressing Prostate Specific Antigen

, &
Pages 161-167 | Published online: 19 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yelena Mirochnik, Marvin Rubenstein & Patrick Guinan. (2007) Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles. Journal of Drug Targeting 15:5, pages 342-350.
Read now

Articles from other publishers (3)

Marvin Rubenstein, Paulus Tsui & Patrick Guinan. (2007) Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. Medical Oncology 24:4, pages 372-378.
Crossref
Marvin Rubenstein, Paulus Tsui & Patrick Guinan. (2007) Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors. Medical Oncology 24:2, pages 189-196.
Crossref
Emily Stone, Tomoko Hirama, Jamshid Tanha, Hong Tong-Sevinc, Shenghua Li, C. Roger MacKenzie & Jianbing Zhang. (2007) The assembly of single domain antibodies into bispecific decavalent molecules. Journal of Immunological Methods 318:1-2, pages 88-94.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.